CPT2 and hepatocellular carcinoma: This was also demonstrated in animal experiments, where CPT2-Azo resulted in the most tumor-killing and inhibitory effects in hepatocellular carcinoma compared to other groups (Figure 7C), and since CPT2-Azo was not converted to the more toxic CPT in normal cells, MCA produced little non-essential toxicity.